Fagron NV - Asset Resilience Ratio

Latest as of December 2025: 0.00%

Fagron NV (FAGR) has an Asset Resilience Ratio of 0.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€11.00K

≈ $12.86K USD Cash + Short-term Investments

Total Assets

€1.24 Billion

≈ $1.45 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Fagron NV's Asset Resilience Ratio has changed over time. Check how strategically is Fagron NV's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Fagron NV's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Fagron NV worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€11.00K	0.0%
Total Liquid Assets	€11.00K	0.00%

Asset Resilience Insights

Limited Liquidity: Fagron NV maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Fagron NV Industry Peers by Asset Resilience Ratio

Compare Fagron NV's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Fagron NV (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Fagron NV.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	€11.00K ≈ $12.86K	€1.24 Billion ≈ $1.45 Billion	-0.08pp
2024-12-31	0.08%	€886.00K ≈ $1.04 Million	€1.08 Billion ≈ $1.27 Billion	-0.34pp
2023-12-31	0.42%	€4.27 Million ≈ $4.99 Million	€1.01 Billion ≈ $1.18 Billion	+0.38pp
2022-12-31	0.05%	€451.00K ≈ $527.27K	€971.01 Million ≈ $1.14 Billion	+0.21pp
2021-12-31	-0.16%	€-1.32 Million ≈ $-1.54 Million	€800.42 Million ≈ $935.78 Million	-0.05pp
2020-12-31	-0.11%	€-862.00K ≈ $-1.01 Million	€752.83 Million ≈ $880.13 Million	+0.14pp
2019-12-31	-0.26%	€-2.07 Million ≈ $-2.42 Million	€801.24 Million ≈ $936.73 Million	-0.45pp
2018-12-31	0.19%	€1.29 Million ≈ $1.51 Million	€682.77 Million ≈ $798.23 Million	+0.22pp
2017-12-31	-0.03%	€-163.00K ≈ $-190.56K	€594.05 Million ≈ $694.50 Million	-0.12pp
2016-12-31	0.09%	€816.00K ≈ $953.99K	€868.05 Million ≈ $1.01 Billion	+0.72pp
2015-12-31	-0.63%	€-4.32 Million ≈ $-5.05 Million	€689.38 Million ≈ $805.96 Million	--

pp = percentage points

About Fagron NV

BR:FAGR Belgium Drug Manufacturers - Specialty & Generic

Market Cap

$2.04 Billion

€1.74 Billion EUR

Market Cap Rank

#6417 Global

#33 in Belgium

Share Price

€23.75

Change (1 day)

+1.50%

52-Week Range

€19.58 - €25.25

All Time High

€25.25